Aravive Inc Platinum Resistant Ovarian Cancer Transcript
Hello, and welcome to Health Professional Radio, I'm your host, Neal Howard. Thank you so much for joining us, again. Going to be speaking this evening with Dr. Gail McIntyre, CEO of Aravive, Inc., and she is joining us here on Health Professional Radio to talk about the urgent need for improved therapeutic approaches to treat patients with ovarian cancer who are resistant to standard care therapy. Welcome to Health Professional Radio, Dr. McIntyre.
Thank you.
Well, I did, of course, mention that you are CEO of Aravive, Inc. Give us a bit of your background and then talk briefly about Aravive's mission.
Sure. So my formal training is in biochemistry and biophysics. Actually I'm a Board Certified in toxicology. I spent 30 years in the drug development business,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |